Business / Finance

RSS

STERIS fourth quarter revenue increases 14% to $377.8 million

STERIS Corporation today announced financial results for its fiscal 2011 fourth quarter ended March 31, 2011. Fiscal 2011 fourth quarter revenue increased 14% to $377.8 million compared with $332.1 million in the fourth quarter of fiscal 2010, with growth in all three business segments.

9 May 2011

U-Systems completes $6.5 million funding round

U-Systems, Inc., the leader in automated breast ultrasound technology, announced today the completion of a $6.5 million funding round. The additional capital came exclusively from existing U-Systems investors and affiliates including iD SoftCapital Group, Lumira Capital, PIIH, Radius Ventures, and Sycamore Ventures.

9 May 2011

Unigene first quarter net loss decreases 58% to $6.6 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced first quarter financial results for the period ended March 31, 2011. The Company highlighted significant progress achieved in the first quarter with the execution of its turnaround strategy.

9 May 2011

Premier healthcare alliance awards new agreements for advanced wound care

The Premier healthcare alliance announced today that new agreements for advanced wound care have been awarded.

9 May 2011

Antares Pharma first quarter total revenues increase to $3.6 million

Antares Pharma, Inc. today reported financial and operating results for the first quarter ended March 31, 2011.

9 May 2011

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").

9 May 2011

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.

9 May 2011

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

MedCath Corporation, a healthcare provider focused on high acuity healthcare services, today announced operating results for its second fiscal quarter ended March 31, 2011. On April 26, 2011, MedCath announced its intention to release the operating results for its second fiscal quarter ended March 31, 2011 on Tuesday, May 10, 2011.

9 May 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

Lovelace Health System, Inc. has signed a definitive agreement to purchase the assets and operations of the Heart Hospital of New Mexico from MedCath Corporation for $119 million.

9 May 2011

GTx reports net loss of $2.6 million for first quarter 2011

GTx, Inc. today provided a company update and reported financial results for the first quarter of 2011.

9 May 2011

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.

9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Flamel Technologies today announced its financial results for the first quarter of 2011.

9 May 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.

9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.

9 May 2011

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

MaxID Pty Ltd, a wholly owned company of MaxID Corp, a leading provider of mobile identity solutions, is pleased to announce that it has won a 1000-unit sale of its iDL500 units in South Africa.

9 May 2011

MedCath sells ownership interest, management agreement in Coastal Carolina Heart to North Carolina hospital

MedCath Corporation announced today it has completed the sale of its ownership interest and management agreement in Coastal Carolina Heart to New Hanover Regional Medical Center.

7 May 2011

Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference

The OPUS Health division of Cegedim Relationship Management conducted a presentation entitled Best Practices in ROI Methodologies in Analyzing the Effectiveness of Patient Co-pay Savings Cards at the 2011 Annual Pharmaceutical Management Science Association Conference in Miami, Florida.

7 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

Business / Finance

STERIS fourth quarter revenue increases 14% to $377.8 million

U-Systems completes $6.5 million funding round

Unigene first quarter net loss decreases 58% to $6.6 million

Premier healthcare alliance awards new agreements for advanced wound care

Antares Pharma first quarter total revenues increase to $3.6 million

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Advanced Cell Technology first quarter net loss decreases to $3.3 million

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

GTx reports net loss of $2.6 million for first quarter 2011

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

caprotec bioanalytics closes Series B financing for EUR 5 million

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

MedCath sells ownership interest, management agreement in Coastal Carolina Heart to North Carolina hospital

Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News